FDA Guidance
- September 11, 2023
-
FDA Guidance
FDA Approves Updated COVID Vaccines The updated vaccines are designed to target currently circulating variants. The CDC's Advisory Committee on Immunization Practices will meet on Sept. 12, 2023 to vote on clinical recommendations related to the updated vaccines.
- Read More
- May 10, 2022
-
FDA Guidance
FDA Limits Use of J&J Vaccine Limitation is due to the J&J vaccine's link to rare but serious blood clots; mRNA vaccines are recommended instead.
- Read More
- February 8, 2022
-
FDA Guidance
Moderna’s COVID-19 Vaccine for 18+ Officially Approved by FDA and CDC The vaccine is no longer under Emergency Use Authorization for 18+.
- Read More
- October 19, 2021
-
FDA Guidance
Additional Vaccine Boosters Moving Through Authorization Process FDA also in early stages of reviewing oral antiviral treatments for COVID-19.
- Read More
- September 21, 2021
-
FDA Guidance
Pfizer Vaccine Boosters Expected Soon; Updated Vaccine Wastage Guidance Issued Boosters recommended for those age 65+, health care workers, and those at high risk for COVID-19.
- Read More
- July 19, 2021
-
FDA Guidance
FDA Announces Revisions to EUA Fact Sheets for Janssen/Johnson & Johnson Vaccine Fact sheets now include information regarding an observed increased risk of Guillain-Barré syndrome.
- Read More